Donghun Investment

Donghun Investment is a venture capital firm based in Seoul, South Korea, that focuses on providing early-stage funding to companies developing technological innovations across various industries. Operating as a subsidiary of the broader Donghoon Group, the firm currently manages two active venture vehicles, including the DongHoon Investment Fund on Early Stage Enterprise, and has previously closed seven additional funds. Throughout its operational history, the organization has executed a total of 29 investments in emerging startups. The firm's investment portfolio features companies such as Neocannbio, which recently received Series B financing, while its executive leadership team includes Chief Executive Officer Seong Taek Kim, Managing Director Kwang Myoung Moon, and Director Min Hyuk Choi. The firm's exact founding year and original founders are not publicly disclosed, though its earliest fund closures date back to 2008.